| Drug Name | KYMRIAH® (tisagenlecleucel) |
|---|---|
| Drug Class |
Anticancer
|
| Risk minimization type |
Patient Card
Other
|
| Specialty (Theraputic area) |
Oncology
|
| Risk |
risk of Cytokine release syndrome and neurological events
|
| Patient card |
|
| other |
Kymriah healthcare professional training material
Patient Educational Leaflet
Patient Educational Leaflet Arabic
Pharmacy/CellLab/Infusion CenterTrainingMaterial |